Atoum Manar Fayiz, Tanashat Reem Qasem, Mahmoud Sameer Al Haj
Department of Medical Laboratory Sciences, Faculty of Allied Health, Hashemite University, Jordan E-mail :
Asian Pac J Cancer Prev. 2013;14(11):7007-10. doi: 10.7314/apjcp.2013.14.11.7007.
In the literature, data concerning the relationship between breast cancer and HLA class II gene polymorphisms are limited, so the aim of this study was to determine if HLA-DQB1 and HLA-DRB1 MHC class-II alleles may confer susceptibility or resistance to the disease among Jordanian females.
This case control study enrolled 56 Royal Hospital breast cancer patients and 60 age matched healthy controls, all of whom provided blood samples (2011-2013). A questionnaire was filled after signing a consent form and DNA was extracted, nucleic acids being amplified for assessment of HLA-DQB1 and HLA-DRB1 alleles by muliplex INNO-LiPA and allele typing carried out by reverse hybridization. Comparison of HLA-DQB1 and HLA-DRB1 allele distributions was carried out with paired t-test and chi-square statistics. Risk factors were assessed by odd ratios with 95% confidence intervals.
A significant negative correlation was observed between HLADQB1* 02 alleles and breast cancers (p=0.013). No significant associations were observed among HLADQB1* 03, 04, 05 and 06 or among HLA-DRB1* 01, 03, 04, 07, 08, 10, 11, 13, 14 and 15.
HLADQB1* 02 alleles may provide positive protection against breast tumor risk among Jordanians, but not HLADQB1* 03, 04, 05 and 06 or HLA-DRB1* 01, 03, 04, 07, 08, 10, 11, 13, 14 and 15 alleles.
在文献中,关于乳腺癌与人类白细胞抗原(HLA)II类基因多态性之间关系的数据有限,因此本研究的目的是确定HLA - DQB1和HLA - DRB1主要组织相容性复合体II类等位基因是否会使约旦女性对该疾病易感或具有抗性。
本病例对照研究纳入了56名皇家医院的乳腺癌患者和60名年龄匹配的健康对照者,所有参与者均提供了血样(2011 - 2013年)。签署知情同意书后填写问卷,提取DNA,通过多重INNO - LiPA扩增核酸以评估HLA - DQB1和HLA - DRB1等位基因,并通过反向杂交进行等位基因分型。采用配对t检验和卡方统计对HLA - DQB1和HLA - DRB1等位基因分布进行比较。通过比值比及95%置信区间评估风险因素。
观察到HLA - DQB102等位基因与乳腺癌之间存在显著负相关(p = 0.013)。在HLA - DQB103、04、05和06之间或HLA - DRB1*01、03、04、07、08、10、11、13、14和15之间未观察到显著关联。
HLA - DQB102等位基因可能为约旦人提供针对乳腺肿瘤风险的正向保护,但HLA - DQB103、04、05和06或HLA - DRB1*01、03、04、07、08、10、11、13、14和15等位基因则不然。